Medtronic to Acquire ATS Medical by GlobalData

VIEWS: 215 PAGES: 7

Medtronic to Acquire ATS Medical

Summary

Medtronic, Inc., a medical device company, signed a definitive agreement to acquire ATS Medical, Inc., a cardiovascular devices company, for a purchase consideration of approximately $370 million or $4 per share in cash. The transaction includes the purchase of ATS Medical stock and assumption of net debt.

The proposed acquisition of ATS Medical is specifically aimed at strengthening and completing Medtronic’s portfolio of therapies for the treatment of cardiac arrythmias and heart valve diseases. Through the acquisition of CryoCath Technologies in 2008 and Ablation Frontiers in 2009, Medtronic acquired a strong portfolio of products that treat cardiac arrythmias in a minimally invasive nature. Simialry, with the acquisition of Corevalve and Ventor Technologies in 2009 the company had acquired a huge portfolio of minimally invasive heart valve replacement technologies. According to GlobalData ATS Medical is a well thought out acquisition made by Medtronic that will add value to Medtronic’s previous acquisitions and its current product portfolio.

Scope

- Details of the agreement included
- Rationale behind the deal
- Strategic fit assessment of ATS and Medtronic’s products
- Company Profiles for ATS Medical and Medtronic

Reasons to buy

- Identify key M&A trends in the medical equipment market
- Track competitor product portfolios and acquisition trends
- Assess future outlook of the companies in question

More Info
									                                                    Medtronic to Acquire ATS Medical
       Reference Code: GDME0014M&A                                                                                                                                   Publication Date: May 2010



       1          Table of Contents
       1 Table of Contents............................................................................................................................................................................... 1
        1.1 List of Tables ............................................................................................................................................................................... 1
        1.2 List of Figures.............................................................................................................................................................................. 1
       2 GlobalData Deal Analysis .................................................................................................................................................................. 2
        2.1 Deal Summary............................................................................................................................................................................. 2
        2.2 Previous Cardiovascular Acquisitions by Medtronic .................................................................................................................... 2
        2.3 Rationale Behind the Acquisition of ATS Medical........................................................................................................................ 2
        2.4 Conclusion .................................................................................................................................................................................. 4
        2.5 Company Profiles ........................................................................................................................................................................ 4
       3 Appendix............................................................................................................................................................................................ 5
        3.1 Research Methodology ............................................................................................................................................................... 5
        3.2 Coverage..................................................................................................................................................................................... 5
        3.3 Secondary Research................................................................................................................................................................... 6
        3.4 Primary Research........................................................................................................................................................................ 6
        3.5 Models......................................................................................................................................................................................... 6
        3.6 Forecasts .................................................................................................................................................................................... 7
        3.7 Expert Panels .............................................................................................................................................................................. 7
        3.8 GlobalData Consulting ................................................................................................................................................................ 7
        3.9 Contact Us .................................................................................................................................................................................. 7
        3.10 Disclaimer ................................................................................................................................................................................... 7



       1.1       List of Tables
       Table 1: Acqusitions, Medtronic, Cardiovascu
								
To top